Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 2

1(33.3%)

3Total

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07263607Phase 2Not Yet Recruiting

A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Role: collaborator

NCT06740773Recruiting

Risk Factors for Complications After Cranioplasty

Role: collaborator

NCT06772311Not Yet Recruiting

Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit

Role: collaborator

NCT06728839Not ApplicableNot Yet Recruiting

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Role: collaborator

NCT06678711Not ApplicableNot Yet Recruiting

Minimally Invasive Atlantoaxial Lateral Mass Joint Fusion (MIS-PALF) As a Surgical Treatment of Atlantoaxial Dislocation

Role: collaborator

NCT03311165Completed

Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)

Role: collaborator

All 6 trials loaded